Search - Université de Rennes Access content directly

Filter your results

11 Results
authFullName_s : David A. Laplaud

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

C. Lebrun , S. Vukusic , V. Abadie , C. Achour , F. Ader et al.
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Journal articles hal-02546158v1

Increased IGM and IGG anti-NEU5GC antibodies in infectious mononucleosis (IMN): link with multiple sclerosis (MS)?

Ludmilla Le Berre , Apolline Salama , Gwénaëlle Evanno , Juliette Rousse , Arnaud Nicot et al.
Xenotransplantation, 2015, 22, pp.S86--S86
Journal articles hal-01245008v1

Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients

Anne Kerbrat , Emmanuelle Le Page , Emmanuelle Leray , T. Anani , M. Coustans et al.
Journal of the Neurological Sciences, 2011, 308 (1-2), pp.98--102. ⟨10.1016/j.jns.2011.05.043⟩
Journal articles istex hal-01147033v1
Image document

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Laetitia Barbin , Chloé Rousseau , Natacha Jousset , Romain Casey , Marc Debouverie et al.
Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
Journal articles hal-01299977v1
Image document

Determinants of Therapeutic Lag in Multiple Sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , J William L Brown et al.
Multiple Sclerosis Journal, 2021, 27 (12), pp.1838-1851. ⟨10.1177/1352458520981300⟩
Journal articles hal-03223056v1

Quelle utilisation des traitements de fond chez des patients ayant une sclérose en plaques rémittente en France sur la période 1990–2017 ? Étude des données de l’Observatoire français de la SEP

Emmanuelle Leray , Jonathan Roux , F. Rollot , Romain Casey , J. de Seze et al.
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2018, 66, pp.S227. ⟨10.1016/j.respe.2018.04.033⟩
Journal articles hal-02921604v1

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients

G. Balloy , Jean Pelletier , L. Suchet , C. Lebrun , M. Cohen et al.
Journal of Neurology, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal articles hal-02066038v1
Image document

New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

Stephane Kremer , Salem Hannoun , Fabrice Bonneville , Francoise Durand-Dubief , Thomas Tourdias et al.
Journal de Neuroradiologie / Journal of Neuroradiology, 2020, 47 (4), pp.250-258. ⟨10.1016/j.neurad.2020.01.083⟩
Journal articles hal-02570313v1

A French observational study about treatment failure under fingolimod in 91 multiple sclerosis patients

Clarisse Carra Dallière , M. Fisselier , M. Cohen , X. Ayrignac , Emmanuelle Le Page et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.701--702
Journal articles hal-01259397v1

Sclérose en plaques et grossesse [Multiple sclerosis and pregnancy]

E. Bodiguel , C. Bensa , D. Brassat , David A. Laplaud , Emmanuelle Le Page et al.
Revue Neurologique, 2014, 170 (4), pp.247--265. ⟨10.1016/j.neurol.2013.09.010⟩
Journal articles hal-01147032v1

MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial

Ayman Tourbah , Christine Lebrun-Frenay , Gilles Edan , M. Clanet , C. Papex et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.785
Journal articles hal-01259396v1